BioNTX Unveils 2024 Rising Stars at the iC³® Life Science & Healthcare Innovation Summit
September 05, 2024 11:06 ET
|
BioNTX
IRVING, Texas, Sept. 05, 2024 (GLOBE NEWSWIRE) -- As Texas continues to grow as a biotech and healthcare innovative hub, BioNTX is honored to announce the 2024 Rising Stars, a select group of...
Lumos Pharma Announces Abstract Accepted for Presentation at September Medical Meeting, SLEP 2024
September 05, 2024 09:00 ET
|
Lumos Pharma, Inc.
AUSTIN, Texas, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical stage biopharmaceutical company focused on therapeutics for rare diseases, announced today that an...
Yseop Joins Veeva’s AI Partner Program to Accelerate Regulatory Document Writing and AI-Driven Content Automation
September 05, 2024 09:00 ET
|
Yseop
NEW YORK, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Yseop, a leader in artificial intelligence (AI) enterprise software, is excited to announce it has joined the Veeva AI Partner Program. As a Veeva AI...
Next Generation Sequencing Market is Anticipated to Attain USD 92.2 Billion in Revenue by 2033 , at a CAGR 23.8%: Insights by Dimension Market Research
September 04, 2024 11:36 ET
|
Dimension Market Research
New York, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Overview The Global Next Generation Sequencing Market size is expected to reach USD 13.5 billion by 2024 and it is further anticipated to reach a...
Plus Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
September 04, 2024 07:30 ET
|
Plus Therapeutics Inc.
Plus Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
GH Research Announces Appointment of Dr. Velichka “Villy” Valcheva to Chief Executive Officer
September 03, 2024 07:00 ET
|
GH Research PLC
DUBLIN, Ireland, Sept. 03, 2024 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological...
CORRECTION: The Global Virus Network Bolsters Multinational Mpox Response Through Critical Meeting of Key Global Partners
August 31, 2024 13:51 ET
|
Global Virus Network
Last week’s meeting marked a prelude to GVN’s international meeting in Durban, South Africa, September 16-18, 2024 TAMPA, Fla., Aug. 31, 2024 (GLOBE NEWSWIRE) -- A correction has been issued for...
The Global Virus Network Bolsters Multinational Mpox Response Through Critical Meeting of Key Global Partners
August 29, 2024 11:48 ET
|
Global Virus Network
Last week’s meeting marked a prelude to GVN’s international meeting in Durban, South Africa, September 16-18, 2024TAMPA, Fla., Aug. 29, 2024 (GLOBE NEWSWIRE) -- To mitigate the mpox outbreak,...
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
August 29, 2024 08:00 ET
|
Phathom Pharmaceuticals
FLORHAM PARK, N.J., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for...
Agile Therapeutics Inc. Announces Completion of Acquisition by Insud Pharma, S.L.
August 26, 2024 17:05 ET
|
Agile Therapeutics, Inc.
Agile Therapeutics has combined with Insud Pharma’s US Subsidiary, Exeltis USA, Inc., expanding an already significant women’s health/contraceptive portfolio Agile Therapeutics Common Shareholders to...